Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Angelalign Technology Inc. ( (HK:6699) ) has shared an announcement.
Angelalign Technology reported strong growth for 2025, driven by surging demand for its clear aligner treatments across both Chinese mainland and overseas markets. Case volume rose 48.1% to about 532,400, with global markets ex‑China up 82.1% and Chinese mainland up 26.3%, underpinning its consolidated market leadership at home and rapid international expansion.
Revenue climbed 37.8% to USD370.3 million, while gross profit increased 38.5% with margins remaining stable at 62.9%. The company’s net profit jumped 163% to USD26.3 million and adjusted net profit rose 63% to USD43.8 million, supported by operating leverage from its global infrastructure, narrower losses in overseas operations, higher profitability in China, and the board’s decision to recommend both a final and a special dividend.
The most recent analyst rating on (HK:6699) stock is a Sell with a HK$66.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.
More about Angelalign Technology Inc.
Angelalign Technology Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates in the clear aligner and orthodontic technology industry. The group designs and sells clear dental aligner treatments, serving both the Chinese mainland and international markets, with a focus on orthodontists who emphasize clinical excellence and strong clinical outcomes.
Average Trading Volume: 608,920
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.19B
For a thorough assessment of 6699 stock, go to TipRanks’ Stock Analysis page.